Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension
Open Access
- 24 April 2009
- journal article
- research article
- Published by Springer Nature in Hypertension Research
- Vol. 32 (6) , 433-437
Abstract
Numerous clinical investigations that have focused on the hypotensive effects of garlic-based preparations have led to controversial results that may be partially because of differences in the composition of the preparations and in the biological responses they induce. It is possible that garlic powder tablets with a prolonged mode of action could induce more potent biological effects. In this double-blind, placebo-controlled trial with an active control arm, the hypotensive action of time-released garlic powder tablets (Allicor) was compared with that of regular garlic pills (Kwai) in 84 men with mild or moderate arterial hypertension. After an 8-week placebo treatment run-in phase, patients were randomized either to 600 mg Allicor (n=30) or to placebo (n=20) daily for 8 weeks. In addition, in the open-label branch, patients received either 2400 mg Allicor daily (n=18) or 900 mg Kwai daily (n=16). Allicor treatment (600 mg daily) resulted in a reduction of both systolic and diastolic blood pressures by 7.0 mm Hg (95% confidence interval (95% CI): 5.3–8.7) and 3.8 mm Hg (95% CI: 2.7–4.8), respectively. Increasing the Allicor dosage to 2400 mg daily did not provide any additional benefit. Treatment with Kwai resulted in the same decrease in systolic blood pressure (5.4 mm Hg, 95% CI: 1.9–8.8) as that seen with Allicor, but no decrease in diastolic blood pressure was observed with Kwai. Different effects of Allicor and Kwai on diastolic blood pressure may be because of the prolonged action of Allicor, which allows better bioavailability of the vasoactive constituents of garlic powder. The results of this study show that time-released garlic powder tablets are more effective for the treatment of mild and moderate arterial hypertension than are regular garlic supplements.Keywords
This publication has 33 references indexed in Scilit:
- Molecular Basis by Which Garlic Suppresses AtherosclerosisThe Journal of Nutrition, 2001
- Sodium-lithium countertransportJournal Of Hypertension, 1998
- A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipidsThe American Journal of Clinical Nutrition, 1996
- Framingham Study Insights into Hypertensive Risk of Cardiovascular Disease.Hypertension Research, 1995
- Garlic supplementation and lipoprotein oxidation susceptibilityLipids, 1993
- Experimental cardiovascular depressant effects of garlic (Allium sativum) dialysateJournal of Ethnopharmacology, 1992
- Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemiaAtherosclerosis, 1988
- The pharmacological effects of allicin, a constituent of garlic oilInflammation Research, 1988
- Effect of an odor-modified garlic preparation on blood lipidsNutrition Research, 1987
- Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery diseaseAtherosclerosis, 1977